MannKind reported 516K in Interest Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Adma Biologics ADMA:US 2.27K 30.8K
BioCryst Pharmaceuticals BCRX:US 609K 555K
ChemoCentryx CCXI:US 509K 287K
Dynavax Technologies DVAX:US 765K 504K
Eli Lilly LLY:US 10.2M 3.2M
Jazz Pharmaceuticals JAZZ:US 700K 500K
Karyopharm Therapeutics KPTI:US 293K 219K
MannKind MNKD:US 516K 139K
Pfizer PFE:US 30M 16M
Xencor XNCR:US 717K 64K